GDF15 and liver disorder: Collectively, these data highlight the complex relationship between inflammatory mediators and liver diseases, positioning GDF-15 and HMGB1 as central mediators of hepatic and systemic inflammation in PALF and further recasting MIG as a chemokine that may help control inflammation.